These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8712323)

  • 1. The influence of cold on the recovery of three neuromuscular blocking agents in man.
    England AJ; Wu X; Richards KM; Redai I; Feldman SA
    Anaesthesia; 1996 Mar; 51(3):236-40. PubMed ID: 8712323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine.
    Kim KS; Lew SH; Cho HY; Cheong MA
    Anesth Analg; 2002 Dec; 95(6):1656-60, table of contents. PubMed ID: 12456433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine potentiation of neuromuscular blocking agents in guinea-pigs.
    Nitahara K; Kornak P; Nagashima H; Vizi ES; Foldes FF; Dan K
    Br J Anaesth; 2000 Feb; 84(2):245-7. PubMed ID: 10743461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of recovery index of rocuronium or vecuronium with simultaneously administered pancuronium in the isolated forearm.
    Fawcett WJ; Fauvel NJ; Feldman SA
    Anaesthesia; 1993 Mar; 48(3):200-1. PubMed ID: 8096371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Train-of-four fade and neuromuscular block in rats: a comparison between pancuronium, vecuronium, and rocuronium.
    Itoh H; Shibata K; Nitta S; Kobayashi T
    Can J Anaesth; 2000 Oct; 47(10):950-5. PubMed ID: 11032268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate of 'onset' and 'offset' of four non-depolarising neuromuscular blocking drugs.
    Feldman SA; Wu X; England A
    Anaesthesia; 1995 Jun; 50(6):510-3. PubMed ID: 7618664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative residual block after intermediate-acting neuromuscular blocking drugs.
    Hayes AH; Mirakhur RK; Breslin DS; Reid JE; McCourt KC
    Anaesthesia; 2001 Apr; 56(4):312-8. PubMed ID: 11284816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation and antagonism of vecuronium by decamethonium.
    Feldman S; Fauvel N
    Anesth Analg; 1993 Mar; 76(3):631-4. PubMed ID: 8095780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The agreement between adductor pollicis mechanomyogram and first dorsal interosseous electromyogram. A pharmacodynamic study of rocuronium and vecuronium.
    Engbaek J; Roed J; Hangaard N; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1994 Nov; 38(8):869-78. PubMed ID: 7887113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative potency of steroidal neuromuscular blocking drugs and isobolographic analysis of the interaction between rocuronium and other aminosteroids.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Jul; 75(1):37-42. PubMed ID: 7669466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
    Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
    Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of action and intubating conditions following vecuronium, rocuronium and mivacurium.
    Wierda JM; Hommes FD; Nap HJ; van den Broek L
    Anaesthesia; 1995 May; 50(5):393-6. PubMed ID: 7793541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org 9487 (rapacuronium) or rocuronium following an initial dose of Org 9487.
    McCourt KC; Mirakhur RK; Lowry DW; Carroll MT; Sparr HJ
    Br J Anaesth; 1999 May; 82(5):755-6. PubMed ID: 10536556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
    McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
    Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to decamethonium neuromuscular block after prior administration of vecuronium.
    Campkin NT; Hood JR; Feldman SA
    Anesth Analg; 1993 Jul; 77(1):78-80. PubMed ID: 8100407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of fading responses induced by non-depolarising muscle relaxants in the evoked EMG of the gastrocnemius muscle of the cat.
    Suzuki T; Nagai H; Katsumata N; Ogawa S; Suzuki H
    Acta Anaesthesiol Scand; 1999 Jul; 43(6):658-62. PubMed ID: 10408821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset and recovery of rocuronium (Org 9426) and vecuronium under enflurane anaesthesia.
    Mayer M; Doenicke A; Hofmann A; Peter K
    Br J Anaesth; 1992 Nov; 69(5):511-2. PubMed ID: 1361356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of neuromuscular action of rocuronium, a new steroidal non-depolarizing agent, with vecuronium.
    Lin PL; Liu CC; Fan SZ; Chao A; Shin SC; Tai YT
    Acta Anaesthesiol Sin; 1997 Sep; 35(3):127-31. PubMed ID: 9407675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.